Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • 1 October 2018 to 31 March 2019
  • Awards: Pump-priming Awards

Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) are fast becoming a new model to investigate cardiovascular abnormalities in the dish.  However, current hiPSC-CM differentiation protocols frequently produce cells that more closely resemble embryonic, or neonatal, rather than adult human cardiomyocytes. This project aims to mature  these cells using different external factors and maturation protocols to produce an improved model to study cardiac disease.

This is a method development project applying different technologies, with the aim of significantly improving the current model of iPSC derived cardiomyocytes. This project aims to provide a valuable method that can be used by cardiovascular researchers and at a later stage may be applied to patient derived iPS cells.

PP86-hiPSC-derived Cardiomyocyte.jpg